Canaccord Adams Reiterates a 'Buy' Rating on Vascular Solutions (VASC); Solid Q1 Results

April 21, 2010 10:04 AM EDT Send to a Friend
Canaccord Adams reiterates a 'Buy' rating on Vascular Solutions (Nasdaq: VASC), price target $11.50.

Canaccord analyst says, "Following a slew ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login